Table 1 Baseline characteristics of participants
From: Association between novel arterial stiffness indices and risk factors of cardiovascular disease
No. of subjects | 7248 | |
Sex | ||
Male | 4083 | [56.3] |
Female | 3165 | [43.7] |
Age (years) | 45.5 ± 5.8 | |
Height (cm) | 165.1 ± 8.5 | |
BMI (kg/m2) | 23.8 ± 4.1 | |
Abdominal circumference (cm) | 82.7 ± 10.5 | |
sBP (mmHg) | 120.5 ± 15.8 | |
dBP (mmHg) | 77.5 ± 10.7 | |
HR (/min) | 66.1 ± 9.4 | |
Hemoglobin (g/dL) | 14.5 ± 1.8 | |
Total protein (g/dL) | 7.1 ± 0.4 | |
Albumin (g/dL) | 4.4 ± 0.2 | |
eGFR (%) | 76.6 ± 12.5 | |
AST (IU/L) | 21.8 ± 12.3 | |
ALT (IU/L) | 24.9 ± 20.0 | |
FPG (mg/dL) | 103.0 ± 20.6 | |
HbA1c (NGSP, %) | 5.5 ± 0.7 | |
Total cholesterol (mg/dL) | 203.2 ± 34.2 | |
LDL cholesterol (mg/dL) | 125.1 ± 33.6 | |
HDL cholesterol (mg/dL) | 65.4 ± 17.8 | |
Triglyceride (mg/dL) | 117.3 ± 108.6 | |
Hypertension | 668 | [9.2] |
Diabetes mellitus | 286 | [3.9] |
Dyslipidemia | 393 | [5.4] |
Medications | ||
Antihypertension | 634 | [8.7] |
Antidiabetes | 219 | [3.0] |
Lipid-lowering | 346 | [4.7] |
Family history of hypertension | 2242 | [30.9] |
Current smoker | 2531 | [34.9] |
API | 25.1 ± 7.0 | |
AVI | 16.6 ± 5.4 |